Näytetään tulokset 1 - 10 / 4447
tulosta / sivu
Mitä julkaisutietoja palvelu sisältää?
Julkaisun nimi
Tekijät
Julkaisukanava
Vuosi

Outcome after discontinuation of TNF alpha-blocking therapy in patients with inflammatory bowel disease in deep remission

Vertaisarvioitu
DOI
10.1097/MIB.0000000000000052
Molander, Pauliina; Farkkila, Martti; Salminen, Kimmo; Kemppainen, Helena; Blomster, Timo; Koskela, ...
Inflammatory bowel diseases2014

CD200 positive human mesenchymal stem cells suppress TNF-alpha secretion from CD200 receptor positive macrophage-like cells

Vertaisarvioitu
Avoin saatavuus
Pietilä, M.; Lehtonen, S.; Tuovinen, Elina; Lähteenmäki, K.; Laitinen, S.; Leskelä, H.V.; Nätynki, A...
PLoS ONE2012

Skin Reactions During Anti-TNF alpha Therapy for Pediatric Inflammatory Bowel Disease:A 2-year Prospective Study

Vertaisarvioitu
DOI
10.1097/MIB.0000000000000088
Malkonen, Tarja; Wikstrom, Anne; Heiskanen, Kaarina; Merras-Salmio, Laura; Mustonen, Harri; Sipponen...
Inflammatory bowel diseases2014

IL-10 to TNF alpha ratios throughout early first trimester can discriminate healthy pregnancies from pregnancy losses

Vertaisarvioitu
DOI
10.1111/aji.13195
Kaislasuo, Janina; Simpson, Samantha; Petersen, Jesper F; Peng, Gang; Aldo, Paulomi; Lokkegaard, Ell...
American journal of reproductive immunology2020

Impact of anti-TNF-alpha therapy on colectomy rate and indications for colectomy in ulcerative colitis:comparison of two patient cohorts from 2005 to 2007 and from 2014 to 2016

Vertaisarvioitu
DOI
10.1080/00365521.2019.1620326
Kolehmainen, Sara; Lepistö, Anna; Färkkilä, Martti
Scandinavian journal of gastroenterology2019

Serum MMPs 7-9 and their inhibitors during glucocorticoid and anti-TNF-alpha therapy in pediatric inflammatory bowel disease

Vertaisarvioitu
DOI
10.3109/00365521.2012.677954
Mäkitalo, Laura; Rintamäki, Hanne; Tervahartiala, Taina; Sorsa, Timo; Kolho, Kaija-Leena
Scandinavian journal of gastroenterology2012

Effectiveness and Safety of Vedolizumab in Anti-TNF-Naive Patients With Inflammatory Bowel Disease-A Multicenter Retrospective European Study

Vertaisarvioitu
DOI
10.1093/ibd/izy155
Kopylov, Uri; Verstockt, Bram; Biedermann, Luc; Sebastian, Shaji; Pugliese, Daniela; Sonnenberg, Ele...
Inflammatory bowel diseases2018

Tumor necrosis factor (TNF)-alpha-308G/A (rs1800629) polymorphism distribution in North India and its association with pemphigus:Case-control study and meta-analysis

Vertaisarvioitu
DOI
10.3109/08916934.2015.1134512
Dar, Sajad Ahmad; Akhter, Naseem; Haque, Shafiul; Singh, Taru; Mandal, Raju Kumar; Ramachandran, Vis...
Autoimmunity2016

Cost-effectiveness of routine measuring of serum drug concentrations and anti-drug antibodies in treatment of rheumatoid arthritis patients with TNF-alpha blockers

Vertaisarvioitu
Avoin saatavuus
DOI
10.2147/BTT.S96982
Laine, Juha; Jokiranta, Sakari; Eklund, Kari ; Väkeväinen, Merja; Puolakka, Kari
Biologics2016

Iron status during anti-TNF therapy in children with juvenile idiopathic arthritis

Vertaisarvioitu
DOI
10.1007/s10067-010-1571-7
Aalto, Kristiina; Honkanen, Visa; Lahdenne, Pekka
Clinical rheumatology2011

Outcome after discontinuation of TNF alpha-blocking therapy in patients with inflammatory bowel disease in deep remission

Vertaisarvioitu
DOI
10.1097/MIB.0000000000000052
2014

CD200 positive human mesenchymal stem cells suppress TNF-alpha secretion from CD200 receptor positive macrophage-like cells

Vertaisarvioitu
Avoin saatavuus
2012

Skin Reactions During Anti-TNF alpha Therapy for Pediatric Inflammatory Bowel Disease:A 2-year Prospective Study

Vertaisarvioitu
DOI
10.1097/MIB.0000000000000088
2014

IL-10 to TNF alpha ratios throughout early first trimester can discriminate healthy pregnancies from pregnancy losses

Vertaisarvioitu
DOI
10.1111/aji.13195
2020

Impact of anti-TNF-alpha therapy on colectomy rate and indications for colectomy in ulcerative colitis:comparison of two patient cohorts from 2005 to 2007 and from 2014 to 2016

Vertaisarvioitu
DOI
10.1080/00365521.2019.1620326
2019

Serum MMPs 7-9 and their inhibitors during glucocorticoid and anti-TNF-alpha therapy in pediatric inflammatory bowel disease

Vertaisarvioitu
DOI
10.3109/00365521.2012.677954
2012

Effectiveness and Safety of Vedolizumab in Anti-TNF-Naive Patients With Inflammatory Bowel Disease-A Multicenter Retrospective European Study

Vertaisarvioitu
DOI
10.1093/ibd/izy155
2018

Tumor necrosis factor (TNF)-alpha-308G/A (rs1800629) polymorphism distribution in North India and its association with pemphigus:Case-control study and meta-analysis

Vertaisarvioitu
DOI
10.3109/08916934.2015.1134512
2016

Cost-effectiveness of routine measuring of serum drug concentrations and anti-drug antibodies in treatment of rheumatoid arthritis patients with TNF-alpha blockers

Vertaisarvioitu
Avoin saatavuus
DOI
10.2147/BTT.S96982
2016

Iron status during anti-TNF therapy in children with juvenile idiopathic arthritis

Vertaisarvioitu
DOI
10.1007/s10067-010-1571-7
2011